Clinical Trials Logo
  1. Home
  2. Hyperaldosteronism
  3. NCT02030587
  4. Details
NCT02030587 Clinical Trial

Laparoscopic Adrenalectomy Versus Radiofrequency Ablation

Hyperaldosteronism Clinical Trial

— LARFA  

Official title:
Laparoscopic Adrenalectomy Versus Radiofrequency Ablation for Aldosterone-producing Adenoma: a Prospective Randomized Controlled Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT02030587
Other study ID # CRE-2012.193-T
Secondary ID
Status Active, not recruiting
Phase N/A
First received January 5, 2014
Last updated April 22, 2017
Start date January 2013
Est. completion date December 2017

Study information
Verified date April 2017
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective randomized controlled study comparing laparoscopic adrenalectomy (LA) versus image-guided percutaneous radiofrequency ablation (RFA) in treating aldosterone-producing adenoma.

The objectives of this study are to

1. compare the short-term outcomes of LA and RFA in treating aldosterone-producing adenoma.

2. compare the treatment success rates of LA and RFA during follow-up for primary aldosteronism.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 36
Est. completion date December 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Hypertensive individuals

2. Biochemically confirmed primary aldosteronism

3. Radiologically confirmed unilateral adrenal adenoma =3cm

Exclusion Criteria:

1. Bilateral adrenal disease

2. Multiple adrenal tumors

3. Other concomitant adrenal diseases

4. Potentially malignant adrenal tumors as shown on imaging

5. Uncorrected coagulopathy

6. Surgically unfit for general anaesthesia

7. Prior open abdominal surgery

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Radiofrequency Ablation

• Laparoscopic Adrenalectomy

Locations
Country Name City State
Hong Kong Prince of Wales Hospital Shatin

Sponsors (1)
Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

References & Publications (1)

Liu SY, Ng EK, Lee PS, Wong SK, Chiu PW, Mui WL, So WY, Chow FC. Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease. Ann Surg. 2010 Dec;252(6):1058-64. doi: 10.1097/SLA.0b013e318f66936. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Morbidity rate 30-day
Primary Resolution of hyperaldosteronism 1 year
Secondary Operative time 24 hours
Secondary Periprocedural hypertensive crisis 24 hours
Secondary Mortality rate 30 days
Secondary Blood loss 24 hours
Secondary Analgesic requirement 30 days
Secondary Time to resumption of activity 30 days
Secondary Resolution of hypokalaemia 1 year
Secondary Blood pressure control 1 year
Secondary Hospital stay 30 days
Secondary Pain score 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT06008184 - Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
Recruiting NCT02945904 - IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Not yet recruiting NCT00553722 - Does Aldosterone Cause Hypertension by a Non-Renal Mechanism? Phase 4
Completed NCT01234220 - Adrenal Vein Sampling International Study (AVIS Study) N/A
Completed NCT00001176 - Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure N/A
Active, not recruiting NCT04605549 - A Study of CIN-107 in Adults With Primary Aldosteronism Phase 2
Not yet recruiting NCT03414918 - Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA) N/A
Not yet recruiting NCT06246357 - Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism Phase 2
Completed NCT02751021 - Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction N/A
Recruiting NCT02832388 - Primary Aldosteronism in Western Norway
Completed NCT00004354 - Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism N/A
Completed NCT01096654 - SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan. Phase 3
Completed NCT00155064 - Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism Phase 4
Recruiting NCT03778645 - Adrenal Venous Sampling Via an Antecubital Approach
Recruiting NCT04328181 - Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) N/A
Completed NCT01897727 - Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment N/A
Recruiting NCT00407784 - Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives. N/A
Recruiting NCT00451672 - The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism Phase 4
Not yet recruiting NCT06192238 - China National Study of Adrenal Venous Sampling